NewsRoom Articles - Page 23 of 154 - PsychedelicNewsWire (PNW)

WednesdaySep 13, 2023 1:19 pm

Michigan Lawmakers Want Congress to Make Psychedelic Research a Priority

Michigan lawmakers want the U.S. Congress, the Department of Veteran Affairs (VA) and the Department of Defense (DOD) to make psychedelic research a priority. Policymakers are calling on Congress to prioritize investment in the research of “nontechnology treatment options” such as psychedelics to expand treatment options for psychological trauma in active and retired military service members. Last week, the Michigan Senate passed a resolution stating that controlled psychedelic clinical trials paired with approaches such as buddy-to-buddy programs, expanded access to service animals and outdoor therapy have “shown promise” as alternative mental-health treatments for veterans. Since House lawmakers advanced the same…

TuesdaySep 12, 2023 10:55 am

Oregon Opens First Nationwide Addiction Treatment Center Leveraging Psilocybin

A collective of trained and experienced psilocybin facilitators in Oregon has launched the country’s first psilocybin-assisted recovery program for addicts. The program is the result of a partnership between Nexus Center for Consciousness and a team of licensed psilocybin facilitators called Moksha Journeys. The program will provide a 28-day retreat for adults looking for alternative addiction-recovery treatments. In addition, the program will offer treatment services such as family therapy, guest counseling, movement coaching, sound therapy and acupuncture treatment as well as outdoor recreational services such as hiking southern Oregon’s forests. The Oregon psilocybin-assisted recovery program will hold its first retreat…

MondaySep 11, 2023 2:42 pm

California House Passes Psychedelics Bill, Resends to Senate

California Assembly members have approved a psychedelic legalization measure passed by the Senate before sending it back to the Senate for discussions on recent amendments. The bill could potentially land on Governor Gavin Newsom’s desk once it advances through the Senate, putting California on track to legalize psychedelic use for eligible adults. Senator Scott Wiener introduced the measure to legalize the cultivation and possession of small amounts of entheogenic fungi and plants for adults aged 21 years and older. The California Assembly passed the psychedelic legalization measure in a 42 to 11 vote. Wiener said Californian first responders, veterans and…

FridaySep 08, 2023 2:17 pm

Lobby Group Suggests Trippers Need to Advise Europe on Psychedelic Policy Reform

With Europe embarking on psychedelic reform and the potential legalization of therapeutic psychedelics, a lobby group comprised of industry players and developers says regulators should leverage knowledge from experienced psychedelic users to inform their decisions. In a document sent to the European Medicines Agency (EMA), the Psychedelic Access Research and European Alliance (PAREA) said the regional bloc needs a standard voice of authority for therapeutic psychedelic use, which includes experienced psychedelic users. The lobby group called for authorities to create a multidisciplinary advisory body to provide professionals and regulators with guidance on best practices for psychedelic-assisted therapies amid the ongoing…

FridaySep 08, 2023 10:30 am

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Is ‘One to Watch’

In July 2023, LSDI launched Twilight, a new sleep aid product The company in July 2023 announced its acquisition of SANA-013 from Wesana Health; SANA-013 is being developed for the treatment of several mental health and central nervous system conditions LSDI in May 2023 launched its new Mindful product line designed to enhance well-being and promote a mindful approach to life Also in May 2023, the company announced a partnership with non-profit TheraPsil to advance medical psilocybin access and research LSDI announced in April 2023 that its board had approved the repurchase of up to 500,000 shares of its Class…

ThursdaySep 07, 2023 3:42 pm

Colorado Seeks Public Views on Implementing Psychedelic Decriminalization

Colorado officials will hold online hearings to gather public opinions on Colorado’s efforts to implement psychedelic decriminalization measures. The state became one of the first regions in the country to pass psychedelic policy after Colorado voters approved a measure to decriminalize several psychedelics for adults aged 21 years and older, setting the state on a path to legalize and regulate psilocybin “healing centers.” Colorado is now seeking public views on implementing psychedelic decriminalization in the state, specifically how the public believes a regulated psychedelic program should look and function. This includes how to train first responders to address psychedelic-related medical…

ThursdaySep 07, 2023 9:30 am

The Strategic Brilliance of Acquiring High Times IP, Including Existing Licensing Agreements and Royalty Streams in All-Stock Transaction

Lucy Scientific Beats MindMed and Seelos Therapeutics to the Punch Lucy Scientific Discovery (NASDAQ: LSDI) (“Lucy” or the “Company), a Nasdaq-listed company with holdings and operations in a variety of psychotropic businesses, just announced the acquisition of the Intellectual Property of High Times, its Licensing Agreements and Royalty Streams in all-stock transaction. This was a brilliant strategic business move. With first movers in the “Mind Science” space like MindMed (NASDAQ: MNMD) and Seelos Therapeutics (NASDAQ: SEEL) realizing than 80% and 40% year-to-date gains respectively, today’s acquisition by Lucy delivers immediate revenue, an expanded product line, a proven and highly influential…

WednesdaySep 06, 2023 1:00 pm

Study Suggests MDMA Could Reduce Uncomfortable Effects of LSD, Psilocybin

Researchers from the Langone Center of Psychedelic Medicine at New York University and the Imperial College London’s Center for Psychedelic Research have published a study suggesting that small doses of MDMA could help reduce the uncomfortable effects of psilocybin and LSD. Psychedelics such as LSD and psilocybin (magic mushrooms) can produce feelings of euphoria and lead to life-changing insights, but they can also induce feelings of discomfort and anxiety in users. Bad trips, as they are referred to, are a relatively common occurrence among psychedelic users and are characterized by symptoms such as extreme paranoia, sudden and extreme mood swings,…

TuesdaySep 05, 2023 12:34 pm

Timothy Leary Expounds on Five Stages Psychedelic Users Could Experience During a Trip

Even though psychedelics have been illegal since the 1970s, psychedelic use among people has surged in recent years, partly due to claims of psychedelics’ therapeutic properties and the fact that younger generations are increasingly moving away from alcohol and tobacco. For people looking to try psychedelics for the first time, acquiring the relevant knowledge and making adequate preparation is the difference between having a positive and impactful psychedelic experience and a negative experience. With that in mind, American psychologist, author and psychedelic advocate Timothy Leary has broken down the psychedelic experience into five key stages or levels. Level 1 is…

FridaySep 01, 2023 1:34 pm

Indigenous People Fight to Retain Traditions of Psychedelic Use as Sacred Medicine

A group of indigenous peoples with a history of traditional and spiritual psychedelic use called the Native Coalition of Colorado protested its lack of involvement in psychedelic discussions during the recent psychedelic conference in Denver. Held during five days in Denver, the Psychedelic Science Conference attracted more than 11,000 attendees from various professions and covered everything from the therapeutic potential of psychedelics to psychedelic-related businesses. The conference was a major indication of America’s increasing acceptance of psychedelics in various industries and is a great indication of the future of psychedelics in America. However, Indigenous peoples who have been using psychedelics…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000